BEUDAMED
    FDA Adverse Event Injury Summary report: Y

    SOFWAVE

    MDR report key: 23427329 · Received October 30, 2025

    Report

    Report Number
    3015889734-2025-00054
    Event Type
    Injury
    Date Received
    October 30, 2025
    Date of Event
    July 22, 2024
    Report Date
    October 23, 2025
    Manufacturer
    SOFWAVE MEDICAL LTD.
    Product Code
    OHV
    UDI-DI
    07290018152003
    PMA / PMN Number
    K250146
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    US
    Reporter Occupation
    OTHER

    Narratives

    Additional Manufacturer Narrative · 0

    ON OCTOBER 21, 2025, SOFTWARE RECEIVED A REPORT FROM FDA DESCRIBING AN EVENT ALLEGING VOLUME LOSS AND FAT AND TISSUE ATROPHY, LAXITY, THINNING, SAGGING AND DESCENT (MW5176208-1) BY THE PATIENT.  DUE TO THE LIMITED INFORMATION PROVIDED AND SINCE THE MANUFACTURER CANNOT CONTACT THE PATIENT AND CANNOT OBTAIN ADDITIONAL INFORMATION, A DETAILED INVESTIGATION COULD NOT BE CONDUCTED.  THE PATIENT REPORTED EXPERIENCING VOLUME LOSS IN THE FACE FOLLOWING USE OF THE DEVICE.  THE MANUFACTURER HAS CONDUCTED AN INTERNAL REVIEW OF DEVICE PERFORMANCE DATA AND DOES NOT BELIEVE THE DEVICE IS CAPABLE OF CAUSING VOLUME LOSS AND FAT AND TISSUE ATROPHY BASED ON ITS DESIGN, INTENDED USE, AND AVAILABLE PERFORMANCE DATA.  THE DEVICE IS DESIGNED TO OPERATE AT A SUPERFICIAL LEVEL AND DOES NOT REACH THE SUBCUTANEOUS FAT LAYER. THE DEVICE'S ULTRASONIC FREQUENCY AND PROPRIETARY TRANSDUCER DESIGN LIMIT ENERGY ABSORPTION TO DEPTHS OF APPROXIMATELY 2 MM, WHICH ARE SUPERFICIAL TO SUBCUTANEOUS FAT. BENCH, PRECLINICAL AND CLINICAL TESTING CONDUCTED DURING DEVELOPMENT AND POST-MARKET SURVEILLANCE HAVE NOT DEMONSTRATED THE POTENTIAL FOR SUBCUTANEOUS FAT LOSS OR TISSUE ATROPHY AT THE ENERGY LEVELS AND DEPTHS DELIVERED BY THE DEVICE.  DEVICE HISTORY RECORDS WERE NOT AVAILABLE DUE TO LACK OF SERIAL OR LOT NUMBER INFORMATION.  BASED ON ITS DESIGN, INTENDED USE, AND AVAILABLE PERFORMANCE DATA, THE MANUFACTURER DOES NOT BELIEVE THE DEVICE IS CAPABLE OF CAUSING VOLUME LOSS OR TISSUE ATROPHY.  THE DEVICE LABELING INCLUDES APPROPRIATE WARNINGS AND PRECAUTIONS CONSISTENT WITH ITS INTENDED USE AND KNOWN RISKS.  THE MANUFACTURER IS UNABLE TO DETERMINE WHETHER THE DEVICE CAUSED OR CONTRIBUTED TO THE REPORTED INJURIES DUE TO THE LACK OF CLINICAL, PROCEDURAL, AND PATIENT-SPECIFIC INFORMATION.  IN ACCORDANCE WITH 21 CFR PART 803, THIS REPORT IS BEING SUBMITTED TO THE FDA BASED ON THE PATIENT'S ALLEGATION OF SERIOUS INJURY. ALTHOUGH THE AVAILABLE INFORMATION IS LIMITED, THE SUBMISSION IS MADE OUT OF AN ABUNDANCE OF CAUTION AND IN COMPLIANCE WITH THE REQUIREMENTS OF 21 CFR PART 803.

    Description of Event or Problem · 0

    ON OCTOBER 21, 2025 SOFTWARE BECAME AWARE OF REPORTABLE EVENT THAT WAS SUBMITTED TO FDA BY A PATIENT (MW5176208-1) ON SEPTEMBER 13, 2025. FDA FORWARDED THE EVENT TO SOFTWARE FOR HANDLING. PATIENT REPORTED THE FOLLOWING: "I WAS SOLD 2 SOFTWARE PROCEDURES BY MY DERMATOLOGIST OFFICE AS A REJUVENATING TREATMENT. IT WAS DONE ON MY ENTIRE FACE, FOREHEAD, SUBMENTAL AND UPPER NECK REGIONS. THIS PROCEDURE CAUSED SIGNIFICANT AND DIFFUSE VOLUME LOSS, FAT AND TISSUE ATROPHY, LAXITY, THINNING, SAGGING AND DESCENT.  I HAD VERY MINIMAL FACE AND NECK LAXITY PRIOR TO SOFTWARE, AND NOW HAVE SIGNIFICANTLY MODERATE LAXITY.  IT CAUSED DEEP LINES AND INDENTATIONS, ESPECIALLY ABOVE THE EYEBROWS TO TEMPLES, LATERAL CHEEKS TO JAW, AND PERIORAL AREAS.  I NOW HAVE DEEP NASOLABIAL LINES AND INDENTATIONS IN THE MARIONETTE REGION.  I HAVE INCREASED LINES AROUND MY LIPS.  THE SUPPORTING LAYER UNDERNEATH MY SKIN DECREASED GREATLY.  THERE IS A LOSS OF SUBDERMAL/SUBCUTANEOUS STRUCTURE AND SUPPORT.  MY SKIN NOW FOLDS AND COLLAPSES IN AREAS IT DID NOT PREVIOUSLY, ESPECIALLY IN THE PERIORAL REGIONS.  THE TENDONS AND BONY STRUCTURES ARE VISIBLE AND MORE PROMINENT ON MY FOREHEAD.  MY ENTIRE FACE; FROM THE FOREHEAD, BROWS, TEMPLES, CHEEKS, CHIN, JAW AND SUBMENTAL DEFLATED, FLATTENED AND DROPPED.  MY EYES WERE SUNKEN IN WITH HOLLOWING AND DARK CIRCLES.  MY UPPER AND LOWER EYELIDS DROOPED.  IT CHANGED MY FACE/SUBMENTAL/NECK CONTOURS AND SHAPE, RESULTING IN A SHRUNKEN, SAD, FLATTENED, PREMATURELY-AGED APPEARANCE.  I NOW HAVE LOOSE, MUSHY, SAGGING TISSUES AROUND MY MOUTH, JAWLINE, CHIN, SUBMENTAL AND UPPER NECK AREAS.  MY FACE, ESPECIALLY THE MID TO LOWER HALF, RECESSED INWARDS RESULTING IN A DISTORTED AND UNBALANCED APPEARANCE.  I REPORTED MY CONCERNS TO THE DERMATOLOGIST CLINIC WHO PERFORMED THE PROCEDURE AND WAS ASKED TO FOLLOW-UP FOR AFTER PHOTOS TO VERIFY THE VOLUME LOSS.  THE VOLUME LOSS WAS CONFIRMED BY THE NURSE WHO PERFORMED THE PROCEDURE AND AN ATTENDING PHYSICIAN, AFTER EXAMINATION AND COMPARING BEFORE AND AFTER CLINICAL PHOTOGRAPHS.  THE NURSE AND ATTENDING PHYSICIAN DISCUSSED SCULPTURE AND FILLERS AS TREATMENT OPTIONS, AND I WAS REFUNDED FOR THE 2ND PROCEDURE I HAD PAID FOR IN ADVANCE.  AFTER CONSULTING WITH MULTIPLE PLASTIC SURGEONS, I WAS TOLD THE DAMAGE IS PERMANENT, CANNOT BE REVERSED, AND WILL REQUIRE FACE, NECK, BROW AND EYE LIFTING SURGERIES, IN ADDITION TO FACIAL AND TISSUE AUGMENTATION THROUGH IMPLANTS AND/OR FAT GRAFTING.  ADDITIONALLY, I HAVE FACIAL AND JAW PAIN, TMD/TMJ, JAW POPPING AND CLICKING, INNER CHEEK RIDGES FROM INADVERTENT CHEEK AND INNER LIP BITING DUE TO THE VOLUME LOSS AND FLATTENED AND SAGGING TISSUES, TRAUMATIC MILIA AND BUBBLE-LIKE SKIN NODULES, SKIN QUALITY AND TEXTURE ISSUES, WHITE STREAK LIKE MARKS, PSYCHOLOGICAL AND EMOTIONAL INJURIES.  THE DAMAGES CONTINUE TO BE INVESTIGATED.  THE CONSENT FORM AND MARKETING MATERIALS I WAS PROVIDED DESCRIBED THE TREATMENT AS HARMLESS WITH NO SERIOUS OR PERMANENT SIDE EFFECTS.  THEY CLAIM THAT IT CANNOT CAUSE FAT LOSS OR DAMAGE TO THE SURROUNDING TISSUES, HOWEVER THAT IS NOT TRUE AS I EXPERIENCED THESE RESULTS.  CLEAR AND RELEVANT WARNINGS MUST BE INCLUDED IN CONSENT FORMS AND MARKETING MATERIALS, SO THAT PATIENTS CAN MAKE A FULLY INFORMED DECISION PRIOR TO UNDERGOING TREATMENT BY A DANGEROUS DEVICE THAT CAN RESULT IN SERIOUS, PERMANENT, AND LIFE-ALTERING ADVERSE EFFECTS.  THE VOLUME LOSS WAS CONFIRMED BY THE PROVIDER WHO PERFORMED THE PROCEDURE VIA BEFORE AND AFTER CLINICAL PHOTOS. I HAVE ALSO SEEN MULTIPLE PLASTIC SURGEONS, MY PRIMARY CARE PROVIDER, NON-COSMETIC DERMATOLOGIST, AND DENTIST RELATED TO THESE ISSUES, IN ADDITION TO ONGOING PSYCHOTHERAPY.  THE DAMAGES CONTINUE TO BE INVESTIGATED."   ADDITIONAL TREATMENT INFORMATION WAS NOT PROVIDED BY FDA AS SEVERAL FIELDS WERE REDACTED.  PATIENT CONTACT INFORMATION WAS NOT AVAILABLE AND THEREFORE FURTHER  FOLLOW-UP WITH THE PATIENT AND INVESTIGATION WAS NOT POSSIBLE. THE SUBJECT REPORTED ON PERMANENT DAMAGE, BUT THE MANUFACTURER CANNOT DETERMINE WHETHER THE INJURY IS DUE TO OR RELATED TO THE DEVICE TREATMENT. THE COMPLAINT HAS LIMITED INFORMATION ON THE TREATMENT AND THE PATIENT TO DETERMINE WHETHER THE DEVICE CAUSED OR CONTRIBUTED TO THE PATIENT'S IDENTIFIED INJURY.  THERE WAS NO MENTION OF ANY DEVICE MALFUNCTION.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    2407733 SOFWAVE SOFWAVE OHV SOFWAVE MEDICAL LTD. SOFWAVE 07290018152003

    Patients

    Seq Age Sex Outcome Treatment
    1 51 YR Female Disability